These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29638079)

  • 1. ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.
    Stukina V; Dohnal J; Saloun J
    Acta Pol Pharm; 2016 Sep; 73(5):1381-1388. PubMed ID: 29638079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
    Liberman J
    J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falsification of medical products: criminal law mechanism combating threats to public health.
    Gutorova N; Zhytnyi O; Soloviov O
    Wiad Lek; 2019; 72(5 cz 1):856-861. PubMed ID: 31175785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating poor-quality anti-malarial medicines: a call to action.
    Bassat Q; Tanner M; Guerin PJ; Stricker K; Hamed K
    Malar J; 2016 Jun; 15():302. PubMed ID: 27251199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globalisation of international health.
    Walt G
    Lancet; 1998 Feb; 351(9100):434-7. PubMed ID: 9482320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
    Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
    Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
    't Hoen E; Pascual F
    J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global counterfeit drug trade: patient safety and public health risks.
    Mackey TK; Liang BA
    J Pharm Sci; 2011 Nov; 100(11):4571-9. PubMed ID: 21698604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beef up international cooperation on counterfeits.
    Shepherd M
    Nat Med; 2010 Apr; 16(4):366. PubMed ID: 20376036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].
    Wittstock M; Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling Counterfeit Drugs: The Challenges and Possibilities.
    Pathak R; Gaur V; Sankrityayan H; Gogtay J
    Pharmaceut Med; 2023 Jul; 37(4):281-290. PubMed ID: 37188891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directional reflectance analysis for identifying counterfeit drugs: Preliminary study.
    Wilczyński S; Koprowski R; Błońska-Fajfrowska B
    J Pharm Biomed Anal; 2016 May; 124():341-346. PubMed ID: 26977587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engendering world conferences: the international women's movement and the United Nations.
    Chen MA
    Third World Q; 1995; 16(3):477-93. PubMed ID: 12319875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.